4//SEC Filing
Hofmeister Robert 4
Accession 0001750019-19-000021
CIK 0001750019other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:06 PM ET
Size
5.3 KB
Accession
0001750019-19-000021
Insider Transaction Report
Form 4
Hofmeister Robert
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-04-11+127,512→ 127,512 totalExercise: $16.11Exp: 2029-04-10→ Common Stock (127,512 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2020, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
Documents
Issuer
TCR2 THERAPEUTICS INC.
CIK 0001750019
Entity typeother
Related Parties
1- filerCIK 0001760102
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:06 PM ET
- Size
- 5.3 KB